Latest Equities News

Tusker Minerals has completed the sale of its Malawi exploration subsidiary to AuKing Mining, receiving $800,000 in cash and 40 million escrowed AuKing shares. The deal gives Tusker further deferred and performance-linked consideration while redirecting its immediate funding capacity towards Cameroon and the retained Mzimba project.

Canterbury Resources is advancing two sizeable Queensland copper projects, but its FY2026 annual report puts the company’s funding position firmly in the spotlight. The explorer ended June with $220,503 in cash and a material uncertainty over its ability to continue as a going concern.

Anatara Lifesciences will manufacture an approximately 10,000-capsule demonstration batch of its AOC anti-obesity compound after deciding further pre-clinical work and an immediate clinical trial are not required. The company ended September with $551,000 in cash, helped by a $318,402 R&D tax rebate.

BKI Investment Company reported a stronger FY2026 and proposed lifting ordinary dividends to 8.00 cents per share in FY2027. The listed investment company also expects first-half ordinary revenue of approximately $38.0 million, while its shares remained at an 11.8% discount to pre-tax net tangible assets at 30 June.

Delorean Corporation has secured a non-binding $20 million financing mandate from Westpac for its NSW1 Horsley Park bioenergy project, taking identified funding to about 81% of the estimated build cost. The project still needs binding finance documents and a further $11.6 million before financial close can be reached.

Macro Metals has secured approximately A$3.28 million through a placement and the proposed conversion of its chairman’s loan, funding drilling across iron ore, copper and gold assets. The raise also completes the acquisition of Yandi South, but much of the capital remains tied to exploration outcomes that are yet to be established.

Rumble Resources has renewed attention on its Earaheedy zinc-lead-silver project, pointing to a 94Mt inferred resource and metallurgical work that produced a 61% zinc-plus-lead bulk concentrate. The company is now testing separate concentrates and seeking strategic partners, but the project remains short of a definitive development case.

WiseTech Global’s FY26 annual report charts a year of extraordinary expansion, with revenue up 79% after the e2open acquisition and underlying EBITDA up 56%. But the stronger earnings base comes with heavier debt, a major workforce reset and unresolved regulatory risks.

Ionic Rare Earths has moved its Belfast magnet recycling project closer to construction while expanding into the United States through a proposed US$100 million joint venture. The progress comes with key funding, approvals and definitive agreements still outstanding.

Carma delivered a much larger operation in FY26, with revenue up 59% and gross profit doubling, but the online used-car retailer remains deeply loss-making. Its next test is converting new sourcing and reconditioning capacity into faster inventory turnover and lower cash burn.

Peninsula Energy’s low-pH uranium restart delivered stronger grades but failed to move enough solution through its Lance wellfields, forcing a guidance withdrawal and a US$50.1 million impairment. The company has fresh funding, but its auditor has warned of material uncertainty over its ability to continue as a going concern.

Mesoblast has reported a sharp commercial step-up in FY2026, with Ryoncil generating US$115.2 million in net sales and total revenue reaching US$120.3 million. The company has also completed treatment in its 350-patient back-pain trial and refinanced its debt, but remains loss-making and expects to need more capital beyond the next 12 months.